相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology
G. Saccomanni et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Celecoxib determination in different layers of skin by a newly developed and validated HPLC-UV method
Fabiola Silva Garcia Praca et al.
BIOMEDICAL CHROMATOGRAPHY (2011)
TLC for pharmaceutical analysis in resource limited countries
Ehangiringa Kaale et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
Review of the applications of different analytical techniques for coxibs research
Malgorzata Starek
TALANTA (2011)
A Novel Transdermal Delivery System for the Anti-Inflammatory Lumiracoxib: Influence of Oleic Acid on In Vitro Percutaneous Absorption and In Vivo Potential Cutaneous Irritation
Tailane Sant'Anna Moreira et al.
AAPS PHARMSCITECH (2010)
Biotransformation of Celecoxib Using Microbial Cultures
Keshetty Srisailam et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2010)
Chromatographic Application on Calixarene Bonded Stationary Phases: A Stability Indicating LC-Method for Determination of Celecoxib in Tablet Formulation
Hisham Hashem et al.
CHROMATOGRAPHIA (2010)
Liquid chromatographic determination of lumiracoxib in pharmaceutical formulations
Paulo R. Oliveira et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Preparation of 125I-celecoxib with high purity as a possible tumor agent
K. M. El-Azony
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2010)
A Validated and Stability-Indicating LC Assay Method for Valdecoxib
T. Satyanarayana Raju et al.
CHROMATOGRAPHIA (2009)
Separation and determination of rofecoxib and its degradation products by TLC chromatography
M. Starek et al.
JOURNAL OF ANALYTICAL CHEMISTRY (2009)
In vivo and in vitro metabolism of lefucoxib in rats
Xuezhi Bi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
High-performance thin-layer chromatographic determination of etoricoxib in the bulk drug and in pharmaceutical dosage form
Gourab Maheshwari et al.
JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC (2007)
Validation of an HPLC method for the determination of valdecoxib and its degradation product:: a mixture of α- and β-n-lactosyl sulfonamide anomers
G. Savic et al.
CHROMATOGRAPHIA (2007)
Quantitative HPLC-UV method for the determination of firocoxib from horse and dog plasma
Valerie Kvaternick et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Recently developed GC/MS and LC/MS methods for determining NSAIDs in water samples
M. Farre et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
High-performance liquid chromatographic determination of parecoxib in human plasma and pharmaceutical formulations
S. M. T. Shaikh et al.
ANALYTICAL LETTERS (2007)
Liquid-chromatographic separation and determination of process-related impurities, including a regio-specific isomer of celecoxib on reversed-phase C18 column dynamically coated with hexamethyldisilazane
R. Nageswara Rao et al.
ANALYTICAL SCIENCES (2006)
Effect of buffer species on the inclusion complexation of acidic drug celecoxib with cyclodextrin in solution
Mahmoud M. Al Omari et al.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY (2006)
Forced-degradation study of valdecoxib as bulk drug and in tablet formulation by HPTLC
thengungal Kochupappy Ravi et al.
JOURNAL OF SEPARATION SCIENCE (2006)
Simple and rapid high-performance liquid chromatographic method for determination of celecoxib in plasma using UV detection: Application in pharmacokinetic studies
A Zarghi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Determination of celecoxib in human plasma and breast milk by high-performance liquid chromatographic assay
M Zhang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects
Janne T. Backman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib
B Hinz et al.
ARTHRITIS AND RHEUMATISM (2006)
Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection
VVP Kumar et al.
BIOMEDICAL CHROMATOGRAPHY (2006)
Development and validation of liquid chromatography method for the separation of valdecoxib and its SC-77852 impurity
M Zecevic et al.
ANALYTICAL LETTERS (2006)
An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices
RN Rao et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Pre-column derivatization of rofecoxib for determination in serum by HPLC
M Amini et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2005)
Validated liquid chromatographic ultraviolet method for the quantitation of Etoricoxib in human plasma using liquid-liquid extraction
NVS Ramakrishna et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
HPLC determination and pharmacokinetic study of valdecoxib in human plasma
RT Sane et al.
CHROMATOGRAPHIA (2005)
Superiority of the gastroduodenal safety profile of licofelone over rofecoxib, a COX-2 selective inhibitor, in dogs
M Moreau et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2005)
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2
R Esser et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
A new stability - Indicating RP-HPLC method to determine assay and known impurity of celecoxib API
AS Jadhav et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2005)
Quantitation of Valdecoxib in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection using liquid-liquid extraction
NVS Ramakrishna et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Collision-induced dissociation of valdecoxib metabolites: a novel rearrangement involving an isoxazole ring
JY Zhang et al.
JOURNAL OF MASS SPECTROMETRY (2004)
Liquid chromatography and chemometric methods for determination of rofecoxib in presence of its photodegradate and alkaline degradation products
MA Shehata et al.
ANALYTICA CHIMICA ACTA (2004)
Determination of rofecoxib in human plasma and breast milk by high-performance liquid chromatographic assay
M Zhang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Isolation, synthesis and characterization of impurities in Celecoxib a cox-2 inhibitor
U Satyanarayana et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Pharmacokinetics of lumiracoxib in plasma and synovial fluid
G Scott et al.
CLINICAL PHARMACOKINETICS (2004)
Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects
JB Mangold et al.
DRUG METABOLISM AND DISPOSITION (2004)
Development and validation of an automated SPE-LC-MS/MS assay for valdecoxib and its hydroxylated metabolite in human plasma
JY Zhang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2003)
Development and validation of an HPLC method for the impurity and quantitative analysis of etoricoxib
R Hartman et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2003)
Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice
JY Zhang et al.
DRUG METABOLISM AND DISPOSITION (2003)
Determination of valdecoxib and its metabolites in human urine by automated solid-phase extraction-liquid chromatography-tandem mass spectrometry
JY Zhang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Simultaneous determination of celecoxib, hydroxycelecoxib, and carboxycelecoxib in human plasma using gradient reversed-phase liquid chromatography with ultraviolet absorbance detection
E Störmer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Monolithic silica liquid chromatography columns for the determination of cyclooxygenase II inhibitors in human plasma
PT Vallano et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Isolation and characterisation of process-related impurities in rofecoxib
KVSRK Reddy et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Examination of rofecoxib solution decomposition under alkaline and photolytic stress conditions
B Mao et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection
F Schönberger et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
High-performance liquid chromatographic-tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies
CM Chavez-Eng et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Simultaneous determination of unlabeled and carbon-13-labeled etoricoxib, a new cyclooxygenase-2 inhibitor, in human plasma using HPLC-MS/MS
MJ Rose et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Stability-indicating methods for the determination of doxazosin mezylate and celecoxib
LI Bebawy et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Development of a derivatization method, coupled with reverse phase HPLC, for monitoring the formation of an enolate intermediate
A Abrahim et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2002)
A stability-indicating HPLC method to determine celecoxib in capsule formulations
PM Dhabu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
A pharmacokinetic study of intramuscular (IM) parecoxib sodium in normal subjects
A Karim et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Selective and rapid liquid chromatography-mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans
U Werner et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
Liquid chromatographic-mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokinetics
M Abdel-Hamid et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
分享论文
